Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
32,621,602
-
Share change
-
+3,625,275
-
Total reported value
-
$863,474,327
-
Put/Call ratio
-
270%
-
Price per share
-
$26.47
-
Number of holders
-
135
-
Value change
-
+$97,263,259
-
Number of buys
-
65
-
Number of sells
-
68
Institutional Holders of ACCELERON PHARMA INC - COMMON STOCK (XLRN) as of Q1 2017
As of 31 Mar 2017,
ACCELERON PHARMA INC - COMMON STOCK (XLRN) was held by
135 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,621,602 shares.
The largest 10 holders included
FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., VANGUARD GROUP INC, Novo A/S, EAGLE ASSET MANAGEMENT INC, WESTFIELD CAPITAL MANAGEMENT CO LP, STATE STREET CORP, Artal Group S.A., and Polar Capital LLP.
This page lists
135
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.